- Home
- INMB vs TWN Comparison
INMB vs TWN Comparison
Compare INMB & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- TWN
- Stock Information
- Founded
- INMB 2015
- TWN 1986
- Country
- INMB United States
- TWN Hong Kong
- Employees
- INMB N/A
- TWN N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- INMB Health Care
- TWN Finance
- Exchange
- INMB Nasdaq
- TWN Nasdaq
- Market Cap
- INMB 176.5M
- TWN 193.5M
- IPO Year
- INMB 2019
- TWN N/A
- Fundamental
- Price
- INMB $2.19
- TWN $44.60
- Analyst Decision
- INMB Strong Buy
- TWN
- Analyst Count
- INMB 3
- TWN 0
- Target Price
- INMB $24.33
- TWN N/A
- AVG Volume (30 Days)
- INMB 5.5M
- TWN 20.1K
- Earning Date
- INMB 07-31-2025
- TWN 01-01-0001
- Dividend Yield
- INMB N/A
- TWN 1.10%
- EPS Growth
- INMB N/A
- TWN N/A
- EPS
- INMB N/A
- TWN N/A
- Revenue
- INMB $50,000.00
- TWN N/A
- Revenue This Year
- INMB $82.14
- TWN N/A
- Revenue Next Year
- INMB $28,750.98
- TWN N/A
- P/E Ratio
- INMB N/A
- TWN N/A
- Revenue Growth
- INMB N/A
- TWN N/A
- 52 Week Low
- INMB $2.00
- TWN $25.22
- 52 Week High
- INMB $11.64
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- INMB 34.68
- TWN 79.46
- Support Level
- INMB $5.60
- TWN $42.17
- Resistance Level
- INMB $7.49
- TWN $44.10
- Average True Range (ATR)
- INMB 1.21
- TWN 0.61
- MACD
- INMB -0.18
- TWN 0.16
- Stochastic Oscillator
- INMB 4.83
- TWN 109.57
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.